Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01925534 · ClinicalTrials.gov registry record · NA
Pilot Study of High-flow Humidified Nasal Oxygen During Breaks From Noninvasive Ventilation
A NA study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT01925534 is a NA study that has completed, run by Tufts Medical Center. The registered enrollment target is 47 participants.
The verdict
NCT01925534, a NA study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether Optiflow, a high-flow humidified oxygen delivery system, is superior to standard oxygen therapy during breaks off noninvasive ventilation in patients affected by acute respiratory failure and in respiratory distress. The investigators anticipate that the Optiflow will provide oxygen more effectively, be more comfortable and permit longer breaks off NIV, shortening the total duration of NIV.
Interventions
- DEVICE High-flow humidified nasal oxygen delivery system
- DEVICE Standard oxygen therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2013-11 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01925534
The ClinicalTrials.gov registry entry for NCT01925534 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High-flow humidified nasal oxygen delivery system is the first listed.
NCT01925534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01925534 about?
NCT01925534 is a clinical study titled "Pilot Study of High-flow Humidified Nasal Oxygen During Breaks From Noninvasive Ventilation". The purpose of this study is to assess whether Optiflow, a high-flow humidified oxygen delivery system, is superior to standard oxygen therapy during breaks off noninvasive ventilation in patients affected by acute respiratory failure and in respiratory distress. The investigators anticipate that th...
What is the current status of trial NCT01925534?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2013-11. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01925534?
The interventions under investigation include: High-flow humidified nasal oxygen delivery system (DEVICE), Standard oxygen therapy (DEVICE).
Who is sponsoring clinical trial NCT01925534?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.